Kuball Laboratories
Kuball Laboratories is at the forefront of cancer research and immunotherapy, pioneering innovative treatment strategies for hematological cancers. They focus on harnessing the power of immune receptor and co-stimulation techniques, developing next-generation predictive models, creating soluble formats for therapeutic applications, and advancing next-generation ATMP development. Their approach translates academic research into clinical successes, facilitating rapid drug development from discovery to application. Key areas include utilizing γδT cells and their receptors for cancer cell therapy, developing 3D predictive models with multiomics and AI, designing bispecific T cell engagers based on innate immune receptors, and integrating GMP simulation for ATMP quality assurance. They also conduct crucial work on cohorts and clinical trials for hematological malignancies to validate new treatments.
Kuball Laboratories
Kuball Laboratories is at the forefront of cancer research and immunotherapy, pioneering innovative treatment strategies for hematological cancers. They focus on harnessing the power of immune receptor and co-stimulation techniques, developing next-generation predictive models, creating soluble formats for therapeutic applications, and advancing next-generation ATMP development. Their approach translates academic research into clinical successes, facilitating rapid drug development from discovery to application. Key areas include utilizing γδT cells and their receptors for cancer cell therapy, developing 3D predictive models with multiomics and AI, designing bispecific T cell engagers based on innate immune receptors, and integrating GMP simulation for ATMP quality assurance. They also conduct crucial work on cohorts and clinical trials for hematological malignancies to validate new treatments.